Beta Blocker News and Research

RSS
Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.
Atenolol beta-blocker may not be effective in reducing heart attacks

Atenolol beta-blocker may not be effective in reducing heart attacks

Noncardiac surgery risky for older heart failure patients

Noncardiac surgery risky for older heart failure patients

High blood pressure can effect many life activities, including sex

High blood pressure can effect many life activities, including sex

Studies confirm that chronic kidney disease independently increases the risk of developing cardiovascular disease

Studies confirm that chronic kidney disease independently increases the risk of developing cardiovascular disease

Celacade shown to reduce risk of death and hospitalization in patients with advanced chronic heart failure

Celacade shown to reduce risk of death and hospitalization in patients with advanced chronic heart failure

Beta-blockers associated with decreased risk for fractures

Beta-blockers associated with decreased risk for fractures

Ramipril reduces rate of sudden cardiac death and nonfatal cardiac arrest by 21 percent

Ramipril reduces rate of sudden cardiac death and nonfatal cardiac arrest by 21 percent

The proper use of drugs to treat heart disease reduces the need for hospital interventions

The proper use of drugs to treat heart disease reduces the need for hospital interventions

No benefit from early PCI/CABG in high risk unstable angina patients

No benefit from early PCI/CABG in high risk unstable angina patients

Atrial fibrillation patients often receive needless treatment

Atrial fibrillation patients often receive needless treatment

New class of compounds play a role in protecting the cardiovascular system

New class of compounds play a role in protecting the cardiovascular system

Nitroxyl-releasing drugs promise to revive failing hearts

Nitroxyl-releasing drugs promise to revive failing hearts

Successful resuscitation rates doubled after upgrade to automated external defibrillators

Successful resuscitation rates doubled after upgrade to automated external defibrillators

New guidelines urge early and long-term treatment with Aldosterone blockade therapy

New guidelines urge early and long-term treatment with Aldosterone blockade therapy

Painless heart attacks often result in greater fatality rates than painful episodes

Painless heart attacks often result in greater fatality rates than painful episodes

Reminder letters to physicians caring for heart attack patients saved lives and cut costs

Reminder letters to physicians caring for heart attack patients saved lives and cut costs

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Findings alleviate concerns of physicians reluctant to prescribe beta-blockers because of cardiovascular adverse effects

Findings alleviate concerns of physicians reluctant to prescribe beta-blockers because of cardiovascular adverse effects

New guidelines for treating heart attacks

New guidelines for treating heart attacks

Regular use of beta-agonist drugs for asthma could be endangering their patients

Regular use of beta-agonist drugs for asthma could be endangering their patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.